195 related articles for article (PubMed ID: 37390202)
41. A truncated form of p23 down-regulates telomerase activity via disruption of Hsp90 function.
Woo SH; An S; Lee HC; Jin HO; Seo SK; Yoo DH; Lee KH; Rhee CH; Choi EJ; Hong SI; Park IC
J Biol Chem; 2009 Nov; 284(45):30871-80. PubMed ID: 19740745
[TBL] [Abstract][Full Text] [Related]
42. The Hsp90 Co-chaperones Sti1, Aha1, and P23 Regulate Adaptive Responses to Antifungal Azoles.
Gu X; Xue W; Yin Y; Liu H; Li S; Sun X
Front Microbiol; 2016; 7():1571. PubMed ID: 27761133
[TBL] [Abstract][Full Text] [Related]
43. Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
Hall JA; Seedarala S; Rice N; Kopel L; Halaweish F; Blagg BS
J Nat Prod; 2015 Apr; 78(4):873-9. PubMed ID: 25756299
[TBL] [Abstract][Full Text] [Related]
44. Binding of p23 and hsp90 during assembly with the progesterone receptor.
Johnson JL; Toft DO
Mol Endocrinol; 1995 Jun; 9(6):670-8. PubMed ID: 8592513
[TBL] [Abstract][Full Text] [Related]
45. Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling.
Oxelmark E; Knoblauch R; Arnal S; Su LF; Schapira M; Garabedian MJ
J Biol Chem; 2003 Sep; 278(38):36547-55. PubMed ID: 12835317
[TBL] [Abstract][Full Text] [Related]
46. Stimulation of the weak ATPase activity of human hsp90 by a client protein.
McLaughlin SH; Smith HW; Jackson SE
J Mol Biol; 2002 Jan; 315(4):787-98. PubMed ID: 11812147
[TBL] [Abstract][Full Text] [Related]
47. The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor.
Kazlauskas A; Sundström S; Poellinger L; Pongratz I
Mol Cell Biol; 2001 Apr; 21(7):2594-607. PubMed ID: 11259606
[TBL] [Abstract][Full Text] [Related]
48. The regulation mechanisms of AhR by molecular chaperone complex.
Kudo I; Hosaka M; Haga A; Tsuji N; Nagata Y; Okada H; Fukuda K; Kakizaki Y; Okamoto T; Grave E; Itoh H
J Biochem; 2018 Mar; 163(3):223-232. PubMed ID: 29092071
[TBL] [Abstract][Full Text] [Related]
49. The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes.
Grenert JP; Johnson BD; Toft DO
J Biol Chem; 1999 Jun; 274(25):17525-33. PubMed ID: 10364185
[TBL] [Abstract][Full Text] [Related]
50. Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer.
Reebye V; Querol Cano L; Lavery DN; Brooke GN; Powell SM; Chotai D; Walker MM; Whitaker HC; Wait R; Hurst HC; Bevan CL
Mol Endocrinol; 2012 Oct; 26(10):1694-706. PubMed ID: 22899854
[TBL] [Abstract][Full Text] [Related]
51. Defective glucocorticoid receptor signaling and keratinocyte-autonomous defects contribute to skin phenotype of mouse embryos lacking the Hsp90 co-chaperone p23.
Madon-Simon M; Grad I; Bayo P; Pérez P; Picard D
PLoS One; 2017; 12(6):e0180035. PubMed ID: 28650975
[TBL] [Abstract][Full Text] [Related]
52. Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle.
Li J; Richter K; Reinstein J; Buchner J
Nat Struct Mol Biol; 2013 Mar; 20(3):326-31. PubMed ID: 23396352
[TBL] [Abstract][Full Text] [Related]
53. The C-terminal region of the human p23 chaperone modulates its structure and function.
Seraphim TV; Gava LM; Mokry DZ; Cagliari TC; Barbosa LR; Ramos CH; Borges JC
Arch Biochem Biophys; 2015 Jan; 565():57-67. PubMed ID: 25447839
[TBL] [Abstract][Full Text] [Related]
54. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery.
Pratt WB; Toft DO
Exp Biol Med (Maywood); 2003 Feb; 228(2):111-33. PubMed ID: 12563018
[TBL] [Abstract][Full Text] [Related]
55. Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex.
Ali MM; Roe SM; Vaughan CK; Meyer P; Panaretou B; Piper PW; Prodromou C; Pearl LH
Nature; 2006 Apr; 440(7087):1013-7. PubMed ID: 16625188
[TBL] [Abstract][Full Text] [Related]
56. Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor.
Kazlauskas A; Poellinger L; Pongratz I
J Biol Chem; 1999 May; 274(19):13519-24. PubMed ID: 10224120
[TBL] [Abstract][Full Text] [Related]
57. Hsp90 oligomerization process: How can p23 drive the chaperone machineries?
Lepvrier E; Nigen M; Moullintraffort L; Chat S; Allegro D; Barbier P; Thomas D; Nazabal A; Garnier C
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1412-24. PubMed ID: 26151834
[TBL] [Abstract][Full Text] [Related]
58. The hsp90 cochaperone p23 is the limiting component of the multiprotein hsp90/hsp70-based chaperone system in vivo where it acts to stabilize the client protein: hsp90 complex.
Morishima Y; Kanelakis KC; Murphy PJ; Lowe ER; Jenkins GJ; Osawa Y; Sunahara RK; Pratt WB
J Biol Chem; 2003 Dec; 278(49):48754-63. PubMed ID: 14507910
[TBL] [Abstract][Full Text] [Related]
59. S100A1 is a novel molecular chaperone and a member of the Hsp70/Hsp90 multichaperone complex.
Okada M; Hatakeyama T; Itoh H; Tokuta N; Tokumitsu H; Kobayashi R
J Biol Chem; 2004 Feb; 279(6):4221-33. PubMed ID: 14638689
[TBL] [Abstract][Full Text] [Related]
60. Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue.
McDowell CL; Bryan Sutton R; Obermann WM
Int J Biol Macromol; 2009 Oct; 45(3):310-4. PubMed ID: 19576239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
